Related Experiment Video
Updated: Jul 31, 2026

Focus Formation: A Cell-based Assay to Determine the Oncogenic Potential of a Gene
Published on: December 31, 2014
Transcriptional control by myb oncogene product
S Ishii1, T Nomura, C Kanei-Ishii
1Laboratory of Molecular Genetics, Tsukuba Life Science Center, Ibaraki, Japan.
Abstract:
Structure and function of two domains of c-Myb were analyzed. We show that a leucine zipper structure is a component of the negative regulatory domain, because its disruption markedly increases both the transactivating and transforming capacities of c-Myb. Our results suggest that an inhibitor which suppresses transactivation binds to c-Myb through the leucine zipper, and that c-Myb can be oncogenically activated by mis-sense mutation. We also proposed a model, the "tryptophan cluster", for the structure of the Myb DNA-binding domain, in which the three tryptophans form a cluster in the hydrophobic core in each repeat. The results of NMR analysis of repeat 3 revealed that the conserved tryptophans play a key role to make the hydrophobic core.
Insights
Disrupting the leucine zipper in c-Myb
Area of Science:
- Molecular Biology
- Protein Structure and Function
- Oncogenesis
Background:
- The c-Myb protein is a transcription factor involved in cell proliferation and differentiation.
- Dysregulation of c-Myb is implicated in various cancers.
- Understanding the structural and functional domains of c-Myb is crucial for deciphering its role in oncogenesis.
Purpose of the Study:
- To analyze the structure and function of two key domains of the c-Myb protein.
- To investigate the role of the leucine zipper in the negative regulatory domain of c-Myb.
- To elucidate the structural model of the Myb DNA-binding domain.
Main Methods:
- Biochemical analysis of protein domains.
- Site-directed mutagenesis to disrupt the leucine zipper structure.
- Nuclear Magnetic Resonance (NMR) spectroscopy to analyze the DNA-binding domain structure.
Main Results:
- Disruption of the leucine zipper significantly enhanced the transactivating and transforming capacities of c-Myb.
- Evidence suggests an inhibitor binds c-Myb via the leucine zipper, suppressing transactivation.
- A "tryptophan cluster" model for the Myb DNA-binding domain was proposed, with NMR confirming the role of conserved tryptophans in the hydrophobic core.
- Oncogenic activation of c-Myb by missense mutation is suggested.
Conclusions:
- The leucine zipper is a critical component of the negative regulatory domain of c-Myb.
- Modulation of the leucine zipper interaction offers a potential therapeutic strategy for c-Myb-driven cancers.
- The "tryptophan cluster" model provides new insights into the structural integrity and function of the Myb DNA-binding domain.
Related Concept Videos
RNA Polymerase II Accessory Proteins
Combinatorial Gene Control
The expression of more than 30,000 genes is controlled by approximately 2000-3000 transcription factors. This is possible because a single transcription factor can recognize more than one regulatory sequence. The specificity in gene...
Master Transcription Regulators
General Transcription Factors
Master Transcription Regulators
Induced Pluripotent Stem Cells
Somatic cells are...

